Minerva Neurosciences shareholders approve reverse stock split ratio of 1:4 to 1:10

Minerva Neurosciences, Inc.

Reverse stock split authorized by 93.5% of votes cast (25.9M for, 1.7M against).
Three directors elected: Hilleman, Laghrissi-Thode, Luthringer (each with ~16M for).
Advisory say-on-pay approved with 17.4M for, 891K against, 9.3M broker non-votes.
Deloitte & Touche ratified as auditor for FY2022 with 27.1M for, 552K against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.